Authors: SKERJANEC A TAWFIK S TAM YK

Citation: A. Skerjanec et al., MECHANISMS OF NONLINEAR PHARMACOKINETICS OF MIBEFRADIL IN CHRONICALLYINSTRUMENTED DOGS, The Journal of pharmacology and experimental therapeutics, 278(2), 1996, pp. 817-825

Authors: SKERJANEC A TAWFIK S TAM YK

Citation: A. Skerjanec et al., NONLINEAR PHARMACOKINETICS OF MIBEFRADIL IN THE DOG, Journal of pharmaceutical sciences, 85(2), 1996, pp. 189-192

Authors: SKERJANEC A TAM YK

Citation: A. Skerjanec et Yk. Tam, HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC ANALYSIS OF MIBEFRADIL IN DOGPLASMA AND URINE, Journal of chromatography B. Biomedical applications, 669(2), 1995, pp. 377-382

Authors: SKERJANEC A CAMPBELL NRC ROBERTSON S TAM YK

Citation: A. Skerjanec et al., PHARMACOKINETICS AND PRESYSTEMIC GUT METABOLISM OF METHYLDOPA IN HEALTHY-HUMAN SUBJECTS, Journal of clinical pharmacology, 35(3), 1995, pp. 275-280

Authors: CAMPBELL NRC SKERJANEC A TAM Y ROBERTSON S BURGESS E

Citation: Nrc. Campbell et al., METHYLDOPA KINETICS BEFORE AND AFTER INGESTION OF METHYLDOPA FOR 8 WEEKS, European Journal of Clinical Pharmacology, 48(5), 1995, pp. 397-400

Authors: SKERJANEC A OBRIEN DW TAM YK

Citation: A. Skerjanec et al., HEPATIC BLOOD-FLOW MEASUREMENTS AND INDOCYANINE GREEN KINETICS IN A CHRONIC DOG-MODEL, Pharmaceutical research, 11(11), 1994, pp. 1511-1515